These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33179521)

  • 1. Furin-responsive triterpenine-based liposomal complex enhances anticervical cancer therapy through size modulation.
    Chen Y; Guo M; Qu D; Liu Y; Guo J; Chen Y
    Drug Deliv; 2020 Dec; 27(1):1608-1624. PubMed ID: 33179521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment.
    Chen Y; Qu D; Fu R; Guo M; Qin Y; Guo J; Chen Y
    Int J Nanomedicine; 2018; 13():7275-7287. PubMed ID: 30510417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin-Functionalized Microemulsions Coloaded with Coix Seed Oil and Tripterine Deeply Penetrate To Improve Cervical Cancer Therapy.
    Guo M; Qu D; Qin Y; Chen Y; Liu Y; Huang M; Chen Y
    Mol Pharm; 2019 Dec; 16(12):4826-4835. PubMed ID: 31663764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequentially Released Liposomes Enhance Anti-Liver Cancer Efficacy of Tetrandrine and Celastrol-Loaded Coix Seed Oil.
    Chen Y; Zhang Z; Qian Z; Ma R; Luan M; Sun Y
    Int J Nanomedicine; 2024; 19():727-742. PubMed ID: 38288265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octanoyl galactose ester-modified microemulsion system self-assembled by coix seed components to enhance tumor targeting and hepatoma therapy.
    Qu D; Liu M; Huang M; Wang L; Chen Y; Liu C; Liu Y
    Int J Nanomedicine; 2017; 12():2045-2059. PubMed ID: 28352174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.
    Chang Q; Geng R; Wang S; Qu D; Kong X
    Drug Deliv; 2016 Nov; 23(9):3629-3638. PubMed ID: 27749106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
    Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
    Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells.
    Qu D; Ma Y; Sun W; Chen Y; Zhou J; Liu C; Huang M
    Int J Nanomedicine; 2015; 10():1173-87. PubMed ID: 25709440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer.
    Zhang L; Wang Y; Yang Y; Liu Y; Ruan S; Zhang Q; Tai X; Chen J; Xia T; Qiu Y; Gao H; He Q
    ACS Appl Mater Interfaces; 2015 May; 7(18):9691-701. PubMed ID: 25845545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicomponent-based microemulsion for boosting ovarian cancer therapy through dual modification with transferrin and SA-R
    Zhao H; Chen M; Zhao Z; Zhu L; Yuan S
    Drug Deliv Transl Res; 2021 Oct; 11(5):1969-1982. PubMed ID: 33006741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
    Han L; Huang R; Liu S; Huang S; Jiang C
    Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
    Wang WY; Cao YX; Zhou X; Wei B
    Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
    Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
    Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
    Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
    Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy.
    Bi Y; Lee RJ; Wang X; Sun Y; Wang M; Li L; Li C; Xie J; Teng L
    Int J Nanomedicine; 2018; 13():5811-5822. PubMed ID: 30323583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
    Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
    Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer.
    Wang F; Chen L; Zhang R; Chen Z; Zhu L
    J Control Release; 2014 Dec; 196():222-33. PubMed ID: 25456829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.